Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen
This study is not yet open for participant recruitment.
Verified October 2013 by Massachusetts General Hospital
Massachusetts General Hospital
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Nina Lin, MD, Massachusetts General Hospital
First received: October 20, 2013
Last updated: October 31, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is not yet open for participant recruitment.|
|Estimated Study Completion Date:||March 2015|
|Estimated Primary Completion Date:||January 2015 (Final data collection date for primary outcome measure)|